BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b

Molecular Endocrinology

Volumn 26, Issue 1, 2012, Pages 87-94

  Kokabu, Shoichiro ^a   Gamer, Laura ^a   Cox, Karen ^a   Lowery, Jonathan ^a   Tsuji, Kunikazu ^b   Raz, Regina ^c   Economides, Aris ^c   Katagiri, Takenobu ^d   Rosen, Vicki ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b Tokyo Medical and Dental University ^*  (Japan)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE 2B; OSTEOGENIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; COLONY FORMING UNIT; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 3; CELL DIFFERENTIATION; CELL LINE; GENE KNOCK-IN TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCYTES; OSTEOGENESIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; STROMAL CELLS;

MUS;

EID: 84855225926     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1168     Document Type: Article

References (39)

1. Urist MR 1965 Bone: formation by autoinduction. Science 150: 893-899
2. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V 1992 Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324
3. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S 1996 Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220:366-371
4. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V 2006 BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424-1429
5. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T 1994 Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766
6. Bianco P, Robey PG, Saggio I, RiminucciM2010 "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther 21:1057-1066
7. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS 2006 A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525-527
8. Fukuda T, Kohda M, Kanomata K, Nojima J, Nakamura A, Kamizono J, Noguchi Y, Iwakiri K, Kondo T, Kurose J, Endo K, Awakura T, Fukushi J, Nakashima Y, Chiyonobu T, Kawara A, Nishida Y, Wada I, Akita M, Komori T, Nakayama K, Nanba A, Maruki Y, Yoda T, Tomoda H, et al. 2009 Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem 284:7149-7156
9. Katagiri T, Suda T, Miyazono K 2008 The bone morphogenetic proteins. New York: Cold Spring Harbor Press
10. Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R 2002 Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7:949-960
11. Hollnagel A, Oehlmann V, Heymer J, Rüther U, Nordheim A 1999 Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-19845
12. Alam N, St-Arnaud R, Lauzier D, Rosen V, Hamdy RC 2009 Are endogenous BMP necessary for bone healing during distraction osteogenesis? Clin Orthop Relat Res 467:3190-3198
13. Qiu T, Wu X, Zhang F, Clemens TL, Wan M, Cao X 2010 TGF-β type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Nat Cell Biol 12:224-234
14. Edwards JR, Nyman JS, Lwin ST, Moore MM, Esparza J, O'Quinn EC, Hart AJ, Biswas S, Patil CA, Lonning S, Mahadevan-Jansen A, Mundy GR 2010 Inhibition of TGF-_ signaling by 1D11 antibody treatment increases bone mass and quality in vivo. J Bone Miner Res 25:2419-2426
15. Pearsall RS, Canalis E, Cornwall-Brady M, Underwood KW, Haigis B, Ucran J, Kumar R, Pobre E, Grinberg A, Werner ED, Glatt V, Stadmeyer L, Smith D, Seehra J, Bouxsein ML 2008 A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc Natl Acad Sci USA 105:7082-7087
16. Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D 2007 Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 148:1654-1665
17. Dickman S 1998 Growing joints use their noggins. Science 280: 1350
18. Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM 2003 Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 34:303-307
19. Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, Cox K, Rosen V, Lyons KM 2001 Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 27:84-88
20. Gamer LW, Cox K, Carlo JM, Rosen V 2009 Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev Dyn 238:2374-2381
21. Paic F, Igwe JC, Nori R, Kronenberg MS, Franceschetti T, Harrington P, Kuo L, Shin DG, Rowe DW, Harris SE, Kalajzic I 2009 Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 45:682-692
22. Gamer LW, Nove J, Levin M, Rosen V 2005 BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in Xenopus embryos. Dev Biol 285:156-168
23. Allendorph GP, Isaacs MJ, Kawakami Y, Izpisua Belmonte JC, Choe S 2007 BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. Biochemistry 46:12238-12247
24. Yeh LC, Tsai AD, Zavala MC, Lee JC 2004 Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells. J Cell Physiol 201: 401-408
25. de Jong DS, van Zoelen EJ, Bauerschmidt S, Olijve W, Steegenga WT 2002 Microarray analysis of bone morphogenetic protein, transforming growth factor β, and activin early response genes during osteoblastic cell differentiation. J Bone Miner Res 17:2119-2129
26. Gamer LW, Tsuji K, Cox K, Capelo LP, Lowery J, Beppu H, Rosen V 2011 BMPR-II is dispensable for formation of the limb skeleton. Genesis 49:719-724
27. Koncarevic A, Cornwall-Brady M, Pullen A, Davies M, Sako D, Liu J, Kumar R, Tomkinson K, Baker T, Umiker B, Monnell T, Grinberg AV, Liharska K, Underwood KW, Ucran JA, Howard E, Barberio J, Spaits M, Pearsall S, Seehra J, Lachey J 2010 A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health. Endocrinology 151: 4289-4300
28. Valenzuela DM, Murphy AJ, Frendewey D, Gale NW, Economides AN, Auerbach W, Poueymirou WT, Adams NC, Rojas J, Yasenchak J, Chernomorsky R, Boucher M, Elsasser AL, Esau L, Zheng J, Griffiths JA, Wang X, Su H, Xue Y, Dominguez MG, Noguera I, Torres R, Macdonald LE, Stewart AF, DeChiara TM, Yancopoulos GD 2003 High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652-659
29. Colnot C, Huang S, Helms J 2006 Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 350:557-561
30. Goldman LA, Cutrone EC, Kotenko SV, Krause CD, Langer JA 1996 Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques 21: 1013-1015
31. Nojima J, Kanomata K, Takada Y, Fukuda T, Kokabu S, Ohte S, Takada T, Tsukui T, Yamamoto TS, Sasanuma H, Yoneyama K, Ueno N, Okazaki Y, Kamijo R, Yoda T, Katagiri T 2010 Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J Biol Chem 285:15577-15586
32. Guo J, Liu M, Yang D, Bouxsein ML, Saito H, Galvin RJ, Kuhstoss SA, Thomas CC, Schipani E, Baron R, Bringhurst FR, Kronenberg HM 2010 Suppression of Wnt signaling by Dkk1 attenuates PTHmediated stromal cell response and new bone formation. Cell Metab 11:161-171
33. Kokabu S, Nojima J, Kanomata K, Ohte S, Yoda T, Fukuda T, Katagiri T 2010 Protein phosphatase magnesium-dependent 1Amediated inhibition of BMP signaling is independent of Smad dephosphorylation. J Bone Miner Res 25:653-660
34. Kanomata K, Kokabu S, Nojima J, Fukuda T, Katagiri T 2009 DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts. Genes Cells 14:695-702
35. Fukuda T, Kokabu S, Ohte S, Sasanuma H, Kanomata K, Yoneyama K, Kato H, Akita M, Oda H, Katagiri T 2010 Canonical Wnts and BMP cooperatively induce osteoblastic differentiation through a GSK3β-dependent and β-catenin-independent mechanism. Differentiation 80:46-52
36. Kokabu S, Ohte S, Sasanuma H, Shin M, Yoneyama K, Murata E, Kanomata K, Nojima J, Ono Y, Yoda T, Fukuda T, Katagiri T 2011 Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Mol Endocrinol 25:474-481
37. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC 2002 Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74-83
38. Hileman SM, Tornøe J, Flier JS, Bjørbaek C 2000 Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby Canine Kidney cells. Endocrinology 141:1955-1961
39. -ΔΔCT method. Methods 25:402-408